What Is the Longevity-Aging Pathway in Genetic Testing?

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on longevity and healthy aging. Browse all Longevity & Telomeres education

The phrase "longevity genetics" means different things depending on who is using it. In consumer genetics, it often means a handful of APOE and FOXO3 results delivered without context. In research genomics, it means genome-wide association studies that identify population-level statistical signals without mechanistic integration. In the PlexusDx Precision Peptide Genetic Test, it means something more specific: 17 insights organized into five functional clusters that map the biological aging system as an interconnected network — not as a list of independent risk variants. Understanding what the Longevity-Aging pathway is, what the 17 insights measure, why they are grouped as a pathway rather than individual results, and how the pathway connects to the other 13 pathways in the 14 pathways, 49 peptides, and 150+ genetic insights of the full panel is the goal of this post.

What a "Pathway" Means in the Longevity-Aging Context

A pathway in the Precision Peptide Genetic Test framework is a set of biologically related genes analyzed as a functional system — where the clinical and biological significance of each variant is understood in the context of the other variants in the same cluster, and where the clusters themselves are understood as interacting components of a larger biological architecture.

The Longevity-Aging pathway's 17 insights are not 17 independent risk scores. They are 17 measurement points across five biological systems that together determine the rate at which a person's biology accumulates the molecular damage, epigenetic drift, mitochondrial dysfunction, and telomere attrition that we recognize as biological aging. Understanding one gene in isolation — FOXO3 rs2802292, for example — tells you something about one node in a network. Understanding all 17 together tells you how the network is configured in a specific individual: where it is genetically robust, where it is genetically constrained, and therefore where the highest-leverage intervention opportunities lie.

This pathway architecture is what makes a 17-insight longevity panel more clinically useful than 17 individual gene results — and more informative than a biological age clock measurement alone, which captures the aggregate output of the system without identifying which components are driving it.

Cluster 1 — Longevity Transcription Factors: The Master Regulatory Layer

Three of the 17 insights govern the transcriptional regulatory layer that controls the cellular stress response, antioxidant gene expression, and the chromatin-level epigenetic regulation of the entire aging program:

FOXO3 (rs2802292) — the forkhead transcription factor that activates antioxidant defense (SOD2, catalase), DNA repair (GADD45A), autophagy (Beclin-1, BNIP3L), and senescent cell clearance in response to oxidative stress and metabolic challenge. FOXO3 is the most replicated longevity-associated gene in human genetics — associated with exceptional longevity in independent cohorts across multiple continents. The G allele at rs2802292 is associated with higher FOXO3 expression and more robust stress response transcription. Full detail: Does FOXO3 Affect How You Age?

NFE2L2 (NRF2 promoter haplotype) — the master antioxidant transcription factor that activates ARE-driven expression of GCLC, GCLM, GSR, GPX1, TXNRD1, and the broader detoxification and antioxidant gene set. NFE2L2 promoter haplotypes (-617C/A, -651G/A, -653A/G) determine basal NRF2 expression and the amplitude of the stress-induced antioxidant gene upregulation response. Low-activity NFE2L2 haplotypes produce attenuated antioxidant defense at baseline and blunted induction under oxidative challenge — the most consequential transcriptional longevity genetic deficit. Full antioxidant system detail: How Does Genetics Affect Antioxidant Capacity?

SIRT1 (expression and activity variants) — the NAD+-dependent deacetylase that activates PGC-1α (mitochondrial biogenesis), p53 (DNA damage response), NF-κB (inflammatory suppression), and FOXO3 (longevity transcription program). SIRT1 activity is determined by both its genetic expression baseline and available NAD+ concentration — making SIRT1 the mechanistic bridge between the longevity transcription factor cluster and the NAD+ homeostasis cluster. Full detail: The SIRT1 Pathway: Genetics, NAD+, and Cellular Repair

Cluster 2 — Antioxidant Defense: The Enzymatic ROS Clearance Layer

Four of the 17 insights map the enzymatic antioxidant systems that execute the ROS clearance program that FOXO3 and NRF2 transcriptionally drive:

SOD2 Val16Ala (rs4880) — mitochondrial superoxide dismutase, determining the efficiency of O₂•⁻ → H₂O₂ dismutation in the mitochondrial matrix. The Val16 (C) allele imports more efficiently into the mitochondrial matrix, producing higher SOD2 activity and lower mitochondrial superoxide steady-state. Full detail: SOD2 and Oxidative Stress: Your Genetic Antioxidant Defense

GPX1 Pro198Leu (rs1050450) — glutathione peroxidase 1, determining the efficiency of H₂O₂ clearance using reduced GSH as the electron donor. Leu/Leu GPX1 reduces H₂O₂ clearance capacity by approximately 30–40%, allowing greater Fenton-derived hydroxyl radical production at equivalent SOD2 output. The SOD2 × GPX1 compound genotype is the primary Layer 1 × Layer 2 antioxidant interaction in the panel.

GCLC (GAG repeat polymorphism and rs17883901 promoter variant) — the rate-limiting enzyme in glutathione synthesis, determining the basal GSH production capacity that both GPX1-mediated H₂O₂ clearance and broad cellular redox buffering depend on. GCLC genotype is the upstream genetic determinant of whether the glutathione substrate pool can sustain GPX1 and GST function under oxidative load. Full detail: What Genes Affect Glutathione Production?

GSTM1 (null deletion polymorphism) — Mu-class glutathione S-transferase activity, governing the conjugation and excretion of electrophilic metabolites and xenobiotics. GSTM1 null deletion (present in approximately 50% of European-ancestry populations) eliminates this conjugation capacity entirely — increasing demand on the GSH pool without increasing synthesis output, most consequentially under high toxicant or oxidative exposure conditions.

Cluster 3 — NAD+ Homeostasis: The Cellular Energy and Repair Currency Layer

Four of the 17 insights map the genetic architecture of NAD+ production and consumption — the metabolic variable that SIRT1 deacetylase activity, PARP1 DNA repair function, and mitochondrial oxidative phosphorylation all depend on:

NAMPT (salvage pathway variants) — nicotinamide phosphoribosyltransferase, the rate-limiting enzyme of the dominant NAD+ salvage pathway. NAMPT activity declines with age and is further constrained by genetic variants reducing enzyme expression — determining how efficiently nicotinamide is recycled to NMN and then to NAD+ in most human tissues.

CD38 (expression variants) — cyclic ADP-ribose hydrolase, the dominant NAD+-consuming enzyme whose expression increases dramatically with the chronic low-grade inflammation of aging. High-activity CD38 genotypes accelerate NAD+ depletion beyond what declining NAMPT salvage capacity can compensate for.

NNMT (expression variants) — nicotinamide N-methyltransferase, which diverts nicotinamide toward methylation and excretion rather than NAMPT-mediated salvage recycling. High-activity NNMT genotypes reduce the nicotinamide available for NAD+ resynthesis, simultaneously increasing SAM (methyl donor) consumption and connecting NAD+ homeostasis to the methylation cycle.

PARP1 Val762Ala (rs13181) — poly-ADP-ribose polymerase 1, which consumes NAD+ at DNA damage sites in proportion to the oxidative DNA damage burden. PARP1 variants affecting catalytic efficiency shape how much NAD+ is consumed per unit of DNA damage — with the highest-impact consequence occurring in individuals who also carry low SOD2 or GPX1 activity genotypes (generating more oxidative DNA damage per unit time). Full NAD+ genetics detail: Can I Increase NAD+ Based on My Genetics?

Cluster 4 — Methylation Cycle: The Epigenetic Aging and Substrate Layer

Two of the 17 insights map the methylation cycle genetics that determines SAM availability, epigenetic aging clock rate, BH4 recycling, cysteine (glutathione substrate) supply, and DNA repair fidelity:

MTHFR C677T (rs1801133) — reduces MTHFR enzyme activity by approximately 35% in heterozygotes and 70% in T/T homozygotes at physiological folate concentrations, impairing 5-MTHF production for methionine regeneration, reducing SAM for methyltransferase reactions, elevating homocysteine with downstream BH4 depletion and eNOS uncoupling, and reducing thymidylate synthesis efficiency with uracil misincorporation consequences for DNA repair fidelity and PARP1-mediated NAD+ consumption.

MTHFR A1298C (rs1801131) — reduces MTHFR enzyme activity through a distinct regulatory domain mechanism, affecting SAM-mediated feedback inhibition rather than catalytic site geometry. Compound C677T/A1298C heterozygosity produces more pronounced functional impairment than either variant alone — making the compound genotype the most methylation-constrained common MTHFR genetic configuration. Full MTHFR longevity detail: MTHFR and Longevity: Are They Connected?

Cluster 5 — Structural Aging Biology: Telomeres, Lipid Metabolism, and the Growth Hormone Axis

The final five of the 17 insights address the structural dimensions of biological aging that the four enzymatic clusters above produce their effects through:

TERT (telomerase reverse transcriptase variants) — the catalytic subunit of telomerase, determining the efficiency with which telomere length is maintained in dividing and stress-exposed cells. TERT expression is activated by both FOXO3 and NRF2 — connecting the transcription factor cluster directly to the telomere maintenance layer. Full detail: Telomeres and TERT: What Genetic Testing Reveals About Cellular Aging

APOE (ε2/ε3/ε4 isoforms) — apolipoprotein E, governing lipid transport, cholesterol metabolism, neuroinflammation, and amyloid clearance. APOE ε4 is the most significant common genetic risk factor for late-onset Alzheimer's disease and impairs the synaptic lipid homeostasis and amyloid-β clearance that neuronal longevity requires. APOE ε2 is protective. Full detail: APOE Genotypes and Healthy Aging: A Deep Dive

IGF1 (pathway variants) — insulin-like growth factor 1 signaling genetics, governing the anabolic growth axis that promotes growth and reproduction in early life but drives accelerated aging through mTOR activation and FOXO3 nuclear exclusion in later life. Lower IGF1 signaling is consistently associated with longevity across model organisms — a relationship that human IGF1 pathway variants partially recapitulate.

GHSR (growth hormone secretagogue receptor variants) — the ghrelin receptor governing growth hormone pulse amplitude, appetite signaling, and the growth hormone axis synchronization to circadian and metabolic state. GHSR variants affecting receptor sensitivity shape growth hormone bioavailability — with consequences for muscle mass maintenance, IGF1 production, and the metabolic aging trajectory. Full growth hormone axis detail: Growth Hormone Axis Genetics: IGF1, GHSR, and Aging

Mitochondrial function (PPARGC1A, TFAM, and related variants) — the nuclear-encoded regulators of mitochondrial biogenesis and mtDNA maintenance that determine mitochondrial density, mtDNA copy number stability, and the cellular energy production capacity that declines as a central feature of biological aging. Full detail: Mitochondrial Function and Genetics: The Cellular Energy Story

How the 17 Insights Work as a Connected System

The five clusters do not operate independently — they form a mutually dependent network where the output of each cluster conditions the context in which the others function:

The transcription factor cluster (FOXO3, NRF2, SIRT1) governs the stress-induced amplification of the antioxidant, NAD+, and DNA repair systems — setting the maximum inducible output across all enzymatic clusters under challenge conditions. Genetically constrained transcription factor capacity means that the enzymatic baselines set by Clusters 2–4 cannot scale up effectively when oxidative or metabolic stress intensifies.

The antioxidant cluster (SOD2, GPX1, GCLC, GSTM1) determines the steady-state ROS clearance that prevents oxidative DNA damage — the primary driver of PARP1-mediated NAD+ consumption in Cluster 3. Lower antioxidant genetic capacity → more oxidative DNA damage → more PARP1 activation → more NAD+ consumed → lower SIRT1 deacetylase activity → reduced FOXO3 activation → reduced antioxidant transcription — a compounding cycle that connects Clusters 1, 2, and 3.

The NAD+ cluster (NAMPT, CD38, NNMT, PARP1) determines cellular NAD+ availability — the substrate that SIRT1 consumes for every deacetylation reaction, and the energetic currency that sustains mitochondrial oxidative phosphorylation in Cluster 5. Lower NAD+ → less SIRT1 activity → less PGC-1α deacetylation → less mitochondrial biogenesis → worse mitochondrial function → more electron leak → more superoxide → more oxidative damage.

The methylation cluster (MTHFR C677T, A1298C) feeds glutathione substrate (cysteine through transsulfuration), BH4 for eNOS coupling, DNA methylation fidelity for epigenetic clock stability, and SAM for the histone methylation that keeps senescence-promoting genes epigenetically silenced. MTHFR impairment undermines Clusters 2, 3, and the epigenetic maintenance function simultaneously.

The structural aging cluster (TERT, APOE, IGF1, GHSR, mitochondrial function) captures the physical aging outputs — telomere length, neurological resilience, anabolic-catabolic balance, and cellular energy production — that all four enzymatic clusters collectively maintain or fail to maintain depending on their genetically determined activity levels.

How the Longevity-Aging Pathway Connects to the Other 13 Pathways

The Longevity-Aging pathway shares genetic variables with multiple other pathways in the 14-pathway panel — connections that make the complete panel more informative than any single pathway analysis:

Methylation & MTHFR pathway: MTHFR C677T and A1298C appear in both the Longevity-Aging and Methylation pathways — in the Longevity context, their epigenetic aging and BH4 consequences are primary; in the Methylation context, their effects on neurotransmitter methylation, homocysteine, and SAH accumulation are primary. The same variants carry different clinical weight depending on which pathway picture is being read.

Sleep pathway: SIRT1 circadian regulation and the NAD+ depletion consequences for circadian clock gene expression (CLOCK, BMAL1 are NAD+-regulated through SIRT1) connect the NAD+ homeostasis cluster in Longevity to circadian function. NAD+ depletion impairs the SIRT1-mediated deacetylation of BMAL1 that drives robust circadian oscillation — making the NAD+ genetic picture relevant to sleep architecture as well as longevity.

Sexual Health pathway: NOS3 genetics (eNOS vascular function) shares mechanistic territory with MTHFR BH4 depletion consequences in the Longevity pathway — MTHFR-driven BH4 insufficiency uncouples eNOS regardless of NOS3 genotype, compounding vascular function consequences across pathways.

Mood pathway: APOE ε4's neuroinflammatory and synaptic lipid metabolism effects overlap with mood pathway neurochemistry variables — the same variants contributing to late-life cognitive decline risk also shape the neuroinflammatory environment that mood regulation depends on earlier in life.

What the Longevity-Aging Pathway Results Reveal

Results from the 17 Longevity-Aging insights are delivered through the secure PlexusDx Results Portal, generated from the Illumina Global Screening Array at CLIA-certified labs, covering 57 unique SNPs across 48 unique genes in the full panel. Each insight is presented with pathway context — the variant's functional role, its interactions with adjacent insights within the cluster, and what the result means in terms of biological tendency rather than diagnosis or prognosis.

The 17 insights do not produce a single "longevity score" — because biological aging is not a single-dimensional process. What they produce is a genetic map of the aging network: where your biology is genetically configured for robust antioxidant defense and efficient NAD+ maintenance, where it is constrained, and therefore where the highest-leverage interventions — whether nutritional, lifestyle, or targeted supplementation — are most relevant to your individual genetic architecture.

The complete guide to all 17 insights and how they connect as a system is in the Complete Guide to Genetic Longevity Testing: 17 Pathway Insights.

The Precision Peptide Genetic Test analyzes how your genes influence longevity and aging pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Ready to see your complete Longevity-Aging pathway profile across all 17 insights? Take the Precision Peptide Genetic Test

Frequently Asked Questions About the Longevity-Aging Pathway

How many insights does the Longevity-Aging pathway contain?

The Longevity-Aging pathway delivers 17 insights across five clusters: longevity transcription factors (FOXO3, NFE2L2, SIRT1), antioxidant defense (SOD2, GPX1, GCLC, GSTM1), NAD+ homeostasis (NAMPT, CD38, NNMT, PARP1), methylation (MTHFR C677T, A1298C), and structural aging biology (TERT, APOE, IGF1, GHSR, mitochondrial). All 17 sit within 14 total pathways and 150+ genetic insights.

How is a pathway analysis different from a standard longevity gene test?

Standard longevity tests report individual variants in isolation. The Longevity-Aging pathway analyzes 17 genes as a connected network — FOXO3 stress response depends on NRF2 amplification; SIRT1 deacetylase activity depends on NAMPT-determined NAD+ availability. Reading genes alone misses these interactions. The Precision Peptide Genetic Test maps all 17 within 14 pathways and 150+ insights.

Can the Longevity-Aging pathway results guide supplementation decisions?

Results reveal genetic tendencies — not diagnoses or prescriptions — designed to be shared with a qualified healthcare provider alongside current biomarkers, metabolic health, and lifestyle. Genetics identifies which enzymatic or methylation bottleneck is most genetically limiting, informing which targeted nutritional inputs are most relevant. Always consult a qualified provider before any supplement protocol changes.

This article is part of the PlexusDx Education Hub. Browse all Longevity & Telomeres education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.